randomized double-blind placebo-controlled trial of acetyl-l-carnitine for als Randomised, double-blind, placebo-controlled, parallel-group, multicentric,
Randomised, double blind, placebo controlled, parallel group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with Medical treatment of autism spectrum disorder in children: Current evidence, controversies, and clinical challenges Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study Journal of Neurology, Neurosurgery & Psychiatry Altered Bioenergetics and Metabolic Homeostasis in Amyotrophic Lateral Sclerosis ScienceDirect
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4



